已发表的部分文献: 标题:YY1:a novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.作者:Yang T, Shu F, Yang H, Heng C, Zhou Y, Chen Y, Qian X, Du L, Zhu X, Lu Q, Yin X;杂志名称:Metabolism 标题:p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.作者:Zhihua Z, Weiwei W, Lihua N, Jianying Z, Jiang G;杂志名称:IUBMB Life 标题:LncRNA SNHG16 induced by TFAP2A modulates glycolysis and proliferation of endometrial carcinoma through miR-490-3p/HK2 axis.作者:Zhang G, Ma A, Jin Y, Pan G, Wang C;杂志名称:Am J Transl Res 标题:Long non-coding RNA ARAP1-AS1 promotes tumorigenesis and metastasis through facilitating proto-oncogene c-Myc translation via dissociating PSF/PTB dimer in cervical cancer.作者:Zhang Y, Wu D, Wang D;杂志名称:Cancer Med 标题:Early-Life Stress Induced Epigenetic Changes of Corticotropin-Releasing Factor Gene in Anorexic Low Body Weight-Selected Chicks.作者:Xiao Y, Wang J, Siegel PB, Cline MA, Gilbert ER;杂志名称:Life (Basel) 标题:P53-induced MRVI1 mediates carcinogenesis of colorectal cancer.作者:Ma L, Wang H, Sun Y, Yang D, Pu L, Zhang X;杂志名称:Scand J Gastroenterol 标题:Remifentanil represses oxidative stress to relieve hepatic ischemia/reperfusion injury via regulating BACH1/PRDX1 axis.作者:You Y, Chen S, Deng H, Xing X, Tang B, Wu Y, Lei E;杂志名称:Clin Res Hepatol Gastroenterol Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。